INTRODUCTION
Creutzfeldt-Jakob disease (CJD) is the most frequent human prion disease, although it is rare. The vast majority of CJD cases are sporadic (about 85%) and calculated prevalence of it is approximately 1-1.5 cases per one million population a year with a worldwide distribution [1] . In Korea, the social anxiety increased a lot regarding import of beef from U.S. in 2008. As a result, CJD including variant CJD has become the center of public interest in Korea. It requires professional experience in the course of diagnosis, and neurologist plays a critical role in the disease surveillance as well as in the diagnosis and management of it. The registration rate and accuracy of diagnosis in Korea are still very low compared to that of developed countries. This study was aimed to investigate the level of awareness, clinical experience and preparedness of Korean neurologists who would encounter the patient of CJD at first place. This study would be used as basic data http://dx.doi.org/10.12779/dnd.2013.12.1.9 www.dementia.or.kr for improving Korean surveillance system and also for better caring and educational system.
METHODS
The survey was performed for the participants on the 31st
Annual Meeting of the Koran Neurological Association in April 2012. Total participants of the meeting were 688 (442 specialists, 246 residents) and 133 neurologists voluntarily responded survey among them. A survey was considered to be the most efficient and accurate measure to evaluate neurologists' current knowledge and practice regarding CJD. The survey questions were developed with 29-item questionnaire (appendix) covered 5 categories which were demographics of neurologists, clinical experience on CJD, diagnosis, terminology and educational/reporting system. It was self-administrated survey and after reviewing of collected data, descriptive statistics, such as percentages and sample size were used to describe how neurologists responded to specific questions.
Most of the data are analyzed according to specialty of neurology (resident or specialist of neurology).
RESULTS

Demographics of the participating neurologists on this survey
Among the neurologists who participated on the 31st Annual Meeting of the Koran Neurological Association in April 2012, 133 members replied on our survey. Eighty-three members were specialists of neurology and 51 members were residents of neurology. Age range of participants distributed from 20s to 50s. About 75% of respondents worked for university hospital. The most frequent city they worked in was Seoul (53.4%) and Gyeonggi-do held the second rank (17.3%) (Table 1).
Clinical experience on CJD
On this survey, 62.4% of the neurologists had cared CJD suspected patients directly and 15% had observed diagnosed cases in their hospital although they had not cared in person, and 19.5 % had not cared CJD suspected patients before (Fig. (Table 3) .
Terminology and awareness
About the terminologies related to CJD, most of the respondents answered that they know well or know a little at least about sporadic CJD (sCJD), variant CJD (vCJD), iatrogenic 
Educational/reporting system
About 44% of neurologists on this survey had heard of the reporting system of suspected CJD patient to public health center but don't know well about it, 34.1% are well aware of it and 11.3% said that they never heard of it. Most of the respondents had participated in the lecture or educational programs related to CJD 1 to 2 times (52.6%) and 24.1% participated more than 3 times but 21.8% never had chance to participated in them. About the question asking the necessity of increasing educational opportunity for neurologists, 67.7% of respondents said "yes" but 30.8% of them thought it wss still enough. About 72.9% of respondent replied that they would participate in the educational program as far as circumstances permit and 23.3% said they would participate for sure. Regarding partial economical supporting system for medical expenses of CJD patients as rare and incurable disease, 45.1% of respondents said that they had never heard of that and 37.6%
had heard of it but don't know well and the proportion of the respondents who knew about it was as low as 16.5% (Table 5) .
DISCUSSION
According to the reported incidence of CJD, it seems to be 50 to 75 patients per year in Korea. Although the incidence is very low, it is important as a fatal disease without cure and should be considered as first differential diagnosis of patients with rapidly progressive dementia. In 2011, the first Korean case of iatrogenic CJD was reported which also increased the public interest among the people [2] . So, the possibility of transfection to other persons by medical devices, operational tools or transfusion also should be considered.
On this survey about 44% of neurologists (n= 52) encountered CJD patients confirmed by biopsy or autopsy (Fig. 2) and it is very high percentage when we consider the low rate of biopsy or autopsy performance in Korea. The reason why it showed high proportion might be the overlapping patients with CJD among the respondents. Twenty-seven percent of respondents answered that CJD might occur more than 40 cases a year but 52.6% of them considered clinically diagnosed CJD would be less than 20 cases, so most neurologists recognized the number of real occurrence of CJD is larger than that of clinically diagnosed cases in Korea. Actually, according to the reports of KCDC, about 30 cases of sporadic CJD have been reported since 2008 annually but estimated occurrence rate of CJD is more than 50 to 60 cases a year in Korea [3] . We do not know the real number of CJD cases because the definite diagnosis of CJD is very rare, and possible diagnosis seems not so valid in Korea. Large proportion of Kore- [5, 6] . Brain MRI showed higher sensitivity and specificity (96% and 93% respectively) in diagnosis of CJD [7] over CSF 14-3-3 protein (sensitivity 86%, specificity 68%) [8] or EEG (sensitivity 64%, specificity 91%) [9] . Regarding question asking diagnostic specificity of each tool on the basis of 95% specificity, most of the neurologists answered that any positive finding of them would be found in other diseases too. So lack of definite diagnostic tool could be one of the causes of increasing difficulty in the diagnosis of CJD in clinical setting. CSF 14-3-3 protein shows low specificity because it can reveal false positive results in other disease such as herpes simplex encephalitis, hypoxic brain damage, brain metastasis, paraneoplastic syndrome or metabolic syndrome [10] .
So other CSF markers such as tau protein or S100b protein are used combined with CSF 14-3-3 protein in some laboratories of other countries [11] . By using cell culture of neurons and glial cells, it is suggested that CSF 14-3-3 protein is just a marker of injured brain tissue rather than that of CJD [12] .
The annual number of suspected CJD patients referred to KCDC is increasing constantly from 51 cases in 2008 to 91 cases in 2010. The positive ratio of CSF 14-3-3 protein among referred cases is more than 50% [3] . About 50% of them who showed CSF 14-3-3 positivity are reported as CJD in Korea. were not confident in the diagnosis of CJD and it was more evident in residents (62.7%) than specialists (31.7%). Two main problems of this diffidence might be due to the lack of clinical experiences because CJD is rare disease (51.9%) and it showed non-specific initial clinical findings (45.1%). So it suggested that there is in need of educational programs to relieve these problems especially for residents. Many neurologists (35%) would transfer CJD suspected patient to other superior hospital for further evaluation or second opinion. This result might be derived from the burden of confirmative diagnosis as CJD which is fatal disease without cure and from difficulties in differential diagnosis because of its variable initial clinical presentations. The most common first sign was reported as cognitive decline such as deficit in attention, memory or judgment [13] . In addition to it, emotional and behavioral change, sleep disorder are also common. Myoclonus, which is especially induced by startling stimulus, might be observed 90% of cases in the course of disease progression.
Extrapyramidal symptoms such as hypokinesia or cerebellar symptoms such as nystagmus, ataxia could be found in two thirds of the patients and 20 to 40% of cases showed them as main symptoms [13] . For example, it was reported that iatrogenic CJD has a tendency of presenting cerebellar symptoms in the early stage of disease [14] . Pyramidal signs such as in- 2) It can be negative in CJD patients although it is rare 3) Initially it could be negative but it would be converted into positive in the course of disease eventually 4) I don't know 8. How many patients would be diagnosed as CJD among the patients who revealed positivity in 14-3-3 protein of CSF in Korea? 1) < 20% 2) 20-39% 3) 40-59% 4) 60-79% 5) 80-100% 6) I don't know 9. What is your opinion about the specificity of diagnostic tools below?
10. Do you think brain biopsy or autopsy is necessary for definite diagnosis of CJD suspected patient? 1) It is necessary although it is certain clinically.
2) It is necessary just in case of confusion in the diagnosis of CJD 3) It is not necessary. 
